TY  - GEN
AU  - Bartlett,Nancy L
AU  - Chen,Robert
AU  - Fanale,Michelle A
AU  - Brice,Pauline
AU  - Gopal,Ajay
AU  - Smith,Scott E
AU  - Advani,Ranjana
AU  - Matous,Jeffrey V
AU  - Ramchandren,Radhakrishnan
AU  - Rosenblatt,Joseph D
AU  - Huebner,Dirk
AU  - Levine,Pamela
AU  - Grove,Laurie
AU  - Forero-Torres,Andres
TI  - Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies
SN  - 1756-8722
PY  - 2015///0102
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Brentuximab Vedotin
KW  - Female
KW  - Hodgkin Disease
KW  - drug therapy
KW  - Humans
KW  - Immunoconjugates
KW  - administration & dosage
KW  - Ki-1 Antigen
KW  - metabolism
KW  - Lymphoma, Large-Cell, Anaplastic
KW  - Male
KW  - Middle Aged
KW  - Molecular Targeted Therapy
KW  - Recurrence
KW  - Retreatment
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/1756-8722-7-24
ER  -